BETHENY DUNN: Open Payments
NPI 1902642028 · KITTANNING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$992 in 50 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $388 · 2025 $992
Food & beverage: $992
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $275 |
| Lilly USA, LLC | 7 | $143 |
| Amgen Inc. | 6 | $107 |
| ABBVIE INC. | 2 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $82 |
| Phathom Pharmaceuticals, Inc. | 3 | $59 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| PFIZER INC. | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
Products named: JARDIANCE, Wegovy, MOUNJARO, QULIPTA, VOQUEZNA, EVENITY, TRELEGY ELLIPTA, PREVNAR 20.
Industry payments across PA — which companies pay providers there.
